The Bcl-2 gene family regulates tissue development and tissue homeostasis t
hrough the interplay of survival and death factors. Family members are char
acterized as either pro-apoptotic or anti-apoptotic, depending on cellular
context. In addition to its anti-apoptotic effect, Bcl-2 also inhibits prog
ression through the cell cycle. Functional interactions between family memb
ers as well as binding to other cellular proteins modulate their activities
. Mammary gland tissue, similar to many other tissues, expresses a number o
f different Bcl-2 relatives including bcl-x, bar, bak, bad, bcl-w, bfl-1, b
cl-2 as well as the bcl-2 binding protein Bag-1. Bcl-2 is expressed in the
nonpregnant mammary gland and early pregnancy. In contrast, expression of b
cl-x and bar continues through late pregnancy, is down-regulated during lac
tation, and upregulated with the start of involution. Bak, bad, bcl-w, and
bfl-1 are also up-regulated during involution. The specific roles of indivi
dual gene products are investigated using dominant gain of function and los
s of function mice. Finally, different Bcl-2 family members are commonly ov
er- or under-expressed in human breast cancers. Bcl-2 expression in human b
reast cancers has been associated with a good prognosis, while decreased Ba
r expression has been linked to poor clinical outcome. Understanding the ro
le Bcl-2 family members play in regulating mammary epithelial cell survival
is salient to both normal mammary gland physiology and the development of
new therapeutic approaches to breast cancer.